Brytyn 50 mg filmom obložene tablete
| Name | Brytyn 50 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-588520213 |
| Active Substance | brivaracetam |
| Composition | jedna filmom obložena tableta sadrži 50 mg brivaracetama |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | PharOS MT Ltd, Birzebbugia, Malta
Pharos Pharmaceutical Oriented Services Ltd., Metamorfossi Attikis, Grčka |
| Marketing Authorisation Holder | Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, Hrvatska |
| Marketing Authorisation Date | 11.02.2026 |
| MA Period of Validity | 11.02.2031 |
| Classification Number | UP/I-530-09/24-01/364 |
| Registration Number | 381-12-01/70-26-20 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N03AX23 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
